J. G. Kuhn

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

D. V. Von Hoff, S. Hilsenbeck, H. Burris, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.

M. Prados, M. Mehta, K. Fink, 2000, Neuro-oncology.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

W. Yung, M. Prados, M. Gilbert, 2011, Neuro-oncology.

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.

Susan M. Chang, W. Yung, M. Prados, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.